NDC 0641-6247 – Fentanyl Citrate
Fentanyl Citrate 50 ug/mL · Injection · Intramuscular, Intravenous
Product NDC0641-6247
Product details
- Brand name
- Fentanyl Citrate
- Generic name
- Fentanyl Citrate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous
- Marketing category
- NDA · NDA019101
- Marketed since
- March 18, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Opioid Agonist
Active ingredients
- Fentanyl Citrate 50 ug/mL
Uses, dosage, side effects and warnings for Fentanyl Citrate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0641-6247-25 | 25 VIAL in 1 CARTON (0641-6247-25) / 1 mL in 1 VIAL (0641-6247-01) | Mar 18, 2021 |
Recalls mentioning this NDC
- D-1139-2015 Jun 24, 2015 · Class III
Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548). - D-0420-2015 Apr 1, 2015 · Class III
Failed Impurities/Degradation Specifications; 12 month stability testing.
Other Fentanyl Citrate products
- 72572-172 Fentanyl Citrate 50 ug/mL · Injection · Civica, Inc.
- 72572-170 Fentanyl Citrate 50 ug/mL · Injection · Civica, Inc.
- 72572-171 Fentanyl Citrate 50 ug/mL · Injection · Civica, Inc.
- 63323-806 Fentanyl Citrate .05 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-808 Fentanyl Citrate 50 ug/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-810 Fentanyl Citrate 100 ug/2mL · Injection, Solution · Fresenius Kabi USA, LLC
- 0641-6027 Fentanyl Citrate 50 ug/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6028 Fentanyl Citrate 50 ug/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6029 Fentanyl Citrate 50 ug/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6030 Fentanyl Citrate 50 ug/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6248 Fentanyl Citrate 50 ug/mL · Injection · Hikma Pharmaceuticals USA Inc.
- 0641-6249 Fentanyl Citrate 50 ug/mL · Injection · Hikma Pharmaceuticals USA Inc.